ConductScience.org, home

Library / Trial comparisons

Expectant Management vs Elective Induction of Labor: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.0009880.0003360.0029wilsonClinicalTrials.gov
Risk in group 20.0006540.0001790.00238wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.000334-0.001510.0023newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.510.2539.04logClinicalTrials.gov
Odds ratio, group 1 over group 21.510.2529.05logClinicalTrials.gov
Number needed to harm, for one more participant with a serious adverse event on Expectant Management than on Elective Induction of Labor2,990from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Expectant ManagementExpectant management (unless a medical indication arises) until at least 40 weeks 5 days.33,037EG000ClinicalTrials.gov
Group 2Elective Induction of Labor
Elective induction of labor between 39 weeks 0 days and 39 weeks 4 days~Elective Induction of Labor: Women randomized to induction of labor will undergo induction via oxytocin at 39 weeks 0 days to 39 weeks 4 days. Those with an unfavorable cervix (modified Bishop score \< 5) will first undergo cervical ripening (method left to the discretion of the patient's physician) in conjunction with or followed by oxytocin stimulation unless a contraindication arises.
23,059EG001ClinicalTrials.gov

Harm 2

FieldValueSource
What it countsTotal, serious adverse eventsClinicalTrials.gov
Time frame
Adverse event data were collected and evaluated from the date of randomization (between 38 weeks, 0 days gestation and 38 weeks, 6 days gestation) through approximately 8 weeks postpartum. This time frame encompasses between 9 and 12 weeks.
ClinicalTrials.gov

Trial 8

FieldValueSource
TitleA Randomized Trial of Induction Versus Expectant ManagementClinicalTrials.gov
NCT numberNCT01990612ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsLabor and DeliveryClinicalTrials.gov
InterventionsElective Induction of LaborClinicalTrials.gov
Lead sponsorThe George Washington University Biostatistics CenterClinicalTrials.gov
Results first posted2019-01-25ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT01990612?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.